Literature DB >> 26203661

A Dutch family with autosomal recessively inherited lower motor neuron predominant motor neuron disease due to optineurin mutations.

Emma Beeldman1, Anneke J van der Kooi1, Marianne de Visser1, Merel C van Maarle2, Fred van Ruissen2, Frank Baas1,2.   

Abstract

Approximately 10% of motor neuron disease (MND) patients report a familial predisposition for MND. Autosomal recessively inherited MND is less common and is most often caused by mutations in the superoxide dismutase 1 (SOD1) gene. In 2010, autosomal recessively inherited mutations in the optineurin (OPTN) gene were found in 1% of Japanese patients with sporadic amyotrophic lateral sclerosis (ALS). Autosomal dominantly inherited OPTN mutations have been described as a cause of primary open-angle glaucoma in the Netherlands and were also found in two Dutch sporadic MND patients. We report the first Dutch family with autosomal recessively inherited MND caused by mutations in the OPTN gene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26203661     DOI: 10.3109/21678421.2015.1066821

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  12 in total

Review 1.  Mendelian neurodegenerative disease genes involved in autophagy.

Authors:  Lidia Wróbel; Sandra Malmgren Hill; Claudia Puri; Sung Min Son; Motoki Fujimaki; Ye Zhu; Eleanna Stamatakou; Farah Siddiqi; Marian Fernandez-Estevez; Marco M Manni; So Jung Park; Julien Villeneuve; David Chaim Rubinsztein
Journal:  Cell Discov       Date:  2020-05-05       Impact factor: 10.849

Review 2.  Autophagy Dysfunction in ALS: from Transport to Protein Degradation.

Authors:  Marta Cozzi; Veronica Ferrari
Journal:  J Mol Neurosci       Date:  2022-06-16       Impact factor: 2.866

3.  Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report.

Authors:  Cyril Pottier; Evadnie Rampersaud; Matt Baker; Gang Wu; Joanne Wuu; Jacob L McCauley; Stephan Zuchner; Rebecca Schule; Christin Bermudez; Sumaira Hussain; Anne Cooley; Marielle Wallace; Jinghui Zhang; J Paul Taylor; Michael Benatar; Rosa Rademakers
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-03-20       Impact factor: 4.092

4.  RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.

Authors:  Yasushi Ito; Dimitry Ofengeim; Ayaz Najafov; Sudeshna Das; Shahram Saberi; Ying Li; Junichi Hitomi; Hong Zhu; Hongbo Chen; Lior Mayo; Jiefei Geng; Palak Amin; Judy Park DeWitt; Adnan Kasim Mookhtiar; Marcus Florez; Amanda Tomie Ouchida; Jian-bing Fan; Manolis Pasparakis; Michelle A Kelliher; John Ravits; Junying Yuan
Journal:  Science       Date:  2016-08-05       Impact factor: 47.728

Review 5.  Necroptosis in neurodegenerative diseases: a potential therapeutic target.

Authors:  Shuo Zhang; Mi-Bo Tang; Hai-Yang Luo; Chang-He Shi; Yu-Ming Xu
Journal:  Cell Death Dis       Date:  2017-06-29       Impact factor: 8.469

Review 6.  Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy.

Authors:  Thomas A Ryan; David A Tumbarello
Journal:  Front Immunol       Date:  2018-05-15       Impact factor: 7.561

Review 7.  Necroptosis in development and diseases.

Authors:  Bing Shan; Heling Pan; Ayaz Najafov; Junying Yuan
Journal:  Genes Dev       Date:  2018-03-01       Impact factor: 11.361

Review 8.  Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.

Authors:  Reka P Toth; Julie D Atkin
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

Review 9.  Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.

Authors:  Robert Weil; Emmanuel Laplantine; Shannel Curic; Pierre Génin
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

Review 10.  The genetics of amyotrophic lateral sclerosis: current insights.

Authors:  Afnan A Alsultan; Rachel Waller; Paul R Heath; Janine Kirby
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.